Literature DB >> 17627163

Holmium laser lithothripsy of ureteral calculi: our initial experience.

A Triantafyllidis1, C Kalaitzis, S Giannakopoulos, A G Papatsoris, T Pantazis, A Papathanasiou, S Touloupidis.   

Abstract

AIM: To evaluate effectiveness and safety of intracorporeal holmium:YAG (Ho:YAG) laser lithotripsy of ureteral calculi. PATIENTS AND METHODS: Between October 2003 and September 2005, 45 patients (age range 27-74, mean age 51.5 years) with 49 ureteral stones (measuring 4-28 mm in size) were treated with Ho:YAG laser lithotripsy. The locations of the stones in the ureter were: 6 in the upper third, 7 in the middle third, and 36 in the lower third. Under general anaesthesia, we used semirigid 9- to 11-Fr ureteroscopes and a flexible 7.5-Fr ureteroscope. The Ho:YAG laser had a maximum power of 1.8 J at 8 Hz, and a 365-mum flexible quartz fibre was used. One month postoperatively the patients were followed up with imaging tests.
RESULTS: Stone disintegration was feasible in all cases. The mean hospital stay was 2.8 days. One month postoperatively, stone-free status was revealed in 93.3% of the cases. Only minor complications were noted in 4 patients (8.8%). No long-term complications were recorded.
CONCLUSION: Ho:YAG laser lithotripsy of ureteral calculi is a feasible, safe, and effective procedure.

Entities:  

Mesh:

Year:  2007        PMID: 17627163     DOI: 10.1159/000102908

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

1.  Correlation between the operation time using two different power settings of a Ho: YAG laser: laser power doesn't influence lithotripsy time.

Authors:  Takashi Kawahara; Hiroki Ito; Hideyuki Terao; Yoshitake Kato; Katsuyuki Tanaka; Takehiko Ogawa; Hiroji Uemura; Yoshinobu Kubota; Junichi Matsuzaki
Journal:  BMC Res Notes       Date:  2013-03-05

Review 2.  Intracorporeal laser lithotripsy.

Authors:  Athanasios G Papatsoris; Andreas Skolarikos; Noor Buchholz
Journal:  Arab J Urol       Date:  2012-03-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.